You'll receive the latest updates on new standards, guidelines, and educational resources, as well as expert insights to help enhance your laboratory's performance and compliance.
January 15, 2026
CLSI Announces 2026 Board of Directors
Malvern, PA – 12/15/2025 – The Clinical and Laboratory Science Institute (CLSI) is pleased to announce its 2026 Board of Directors. The slate this year includes ...4 new directors, a new board President, Board Secretary, and a President-elect who will collectively help advance our mission to promote laboratory excellence and quality testing.
Malvern, PA – 12/15/2025 – The Clinical and Laboratory Science Institute (CLSI) is pleased to announce its 2026 Board of Directors. The slate this year includes ...4 new directors, a new board President, Board Secretary, and a President-elect who will collectively help advance our mission to promote laboratory excellence and quality testing.
“The Board of Directors for CLSI acts as the guiding light and the driving force behind our mission, and their actions impact millions of people around the world. I am eternally grateful to work alongside such an esteemed group of leaders in their fields,” said CLSI CEO Dr. Barb Jones.
2026 CLSI Board of Directors
*New Board Member
President
Dr. Gary W. Procop, MS, MEd
CEO, American Board of Pathology
President Elect*
Dr. Loralie J. Langman, DABCC, FACB, F-ABFT
Professor of Laboratory Medicine and Pathology, Mayo Clinic
Treasurer
Joseph Passarelli
Retired, Roche Diagnostics
Secretary
Paula M. Snippes Vagnone, MT(ASCP)Microbiology
Supervisor, Minnesota Department of Health
Immediate Past President
Dr. James H. Nichols, DABCC, FADLM
Professor of Path/Micro/Immunology, Vanderbilt University School of Medicine
Members
Dr. Lorin Bachmann, DABCC, MT(ASCP)
Co-Director of Clinical Chemistry, Virginia Commonwealth University Health System
Dr. Victor R. De Jesus
Chief, Quality Systems Branch, Division of Laboratory Systems, Center for Surveillance, Epidemiology, and Laboratory Services
Dr. Jamie Phillips Deeter, MS*
Scientific Affairs, Senior Director, Roche Diagnostics
Debra Kuehl, MS, M(ASCP)
Deputy Associate Director for Laboratory Science, Centers for Disease Control and Prevention
Dr. Michael Loeffelholz, D(ABMM)
VP, Scientific Affairs, Cepheid
Dr. Marianela Perez-Torres, MT*
Supervisory Biologist, FDA Center for Devices and Radiological Health
Dr. Zahra Shajani-Yi, DABCC(CC), FADLM, NRCC-CC
Senior Clinical Chemist and Technical Director II, LabCorp San Diego
At-Large Member
Dr. Randall T. Hayden
Director, Clinical and Molecular Microbiology
Ex Officio Non-voting Member
Victoria Petrides, MS
Program Manager, Technical Design Quality, Abbott
The Board of Directors at CLSI serves as the governing body responsible for shaping organizational priorities, ensuring transparency, and supporting CLSI’s mission to advance quality laboratory medicine worldwide. Their collective expertise helps drive strategic decision-making and foster collaboration across the global laboratory community.
The CLSI Board is made up of balanced representation from government, industry, and health care and helps to ensure impartiality in decision-making at the organization’s highest level. Board members serve for terms of xx years and a maximum of xx years.
For more information about CLSI and its Board of Directors, please visit here.
CLSI is the leading global non-profit laboratory medicine standards development organization, with over 24,000 professional members, 2000 active volunteers, and 300+ standards products. CLSI standards are recognized by laboratories, accreditors, and government agencies worldwide as the best way to improve their testing outcomes, maintain accreditation, bring products to market faster, and navigate regulatory hurdles.